英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

comfortless    
a. 无安慰的,不舒服的,不自由的

无安慰的,不舒服的,不自由的

comfortless
adj 1: without comfort; "a comfortless room"


请选择你想看的字典辞典:
单词字典翻译
comfortless查看 comfortless 在百度字典中的解释百度英翻中〔查看〕
comfortless查看 comfortless 在Google字典中的解释Google英翻中〔查看〕
comfortless查看 comfortless 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Careers – Larimar Therapeutics
    Careers Be part of the Larimar team! Larimar is a dynamic company seeking to develop treatments that improve the lives of patients with rare diseases We are collaborative, creative and rigorous in our approaches The company is located in the greater Philadelphia area
  • Presentations - Larimar Therapeutics, Inc.
    © 2026 Larimar Therapeutics, Inc All rights reserved LARIMAR and LARIMAR THERAPEUTICS are trademarks of Larimar Therapeutics, Inc
  • Larimar Therapeutics
    Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases The company’s lead product candidate, nomlabofusp (previously known as CTI-1601), is currently being evaluated in a Phase 2 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive
  • Financials Filings - Larimar Therapeutics, Inc.
    EX-101 SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML Apr 10, 2026
  • Gopi Shankar, PhD, MBA, FAAPS – Larimar Therapeutics
    Gopi Shankar, PhD, MBA, FAAPS, joined Larimar Therapeutics in February, 2023 as Chief Development Officer bringing over 20 years of experience leading the development of novel biologics, most recently as Vice President and Global Head, Biologics Development Sciences at Janssen Research Development (a pharmaceutical company of Johnson Johnson, Inc ) In this role, Dr Shankar led a global
  • Larimar Therapeutics Reports Positive Open Label Data and Submission of . . .
    About Larimar Therapeutics Larimar Therapeutics, Inc (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases Larimar’s lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's ataxia
  • Nomlabofusp – Larimar Therapeutics
    Larimar’s nomlabofusp development program was also selected by the FDA to participate in its START (Support for clinical Trials Advancing Rare disease Therapeutics) pilot program, which is designed to accelerate development of novel therapies intended to address an unmet medical need for rare diseases About Friedreich’s Ataxia (FA)
  • Carole Ben-Maimon, MD – Larimar Therapeutics
    Carole Ben-Maimon, MD, joined Larimar Therapeutics in December 2016 as the President and Chief Executive Officer, bringing more than 25 years’ experience in the pharmaceutical industry to the company
  • Annual Reports and Proxy Materials - Larimar Therapeutics, Inc.
    There are no items to display PROXY STATEMENTS
  • Directions – Larimar Therapeutics
    Larimar Therapeutics Three Bala Plaza East Suite 506 Bala Cynwyd, PA 19004 Please note: If you are using a GPS locator, enter the street address of 251 St Asaphs Road, Bala Cynwyd, PA 19004





中文字典-英文字典  2005-2009